Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019829 (
Hodgkin's disease
)
30,247
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient who had been treated for
Hodgkin's disease
was infected with
herpes zoster
. Shortly thereafter, glomerulonephritis mediated by anti-glomerular basement membrane (anti-GBM) antibody occurred. The diagnosis was confirmed by the presence of circulating anti-GBM antibody, immunofluorescence, and elution. Results of immunofluorescence of a lymph node disclosed deposits of IgG on the vascular and stromal connective tissue, in a pattern similar to that seen when heterologous anti-GBM antibody reacted with the node. Because of the known nephritogenic potential of solid lymphoid tissues, this finding suggests a possible relationship between his tumor and his glomerular disease. The role of zoster infection remains undefined.
...
PMID:Glomerulonephritis with Hodgkin's disease and herpes zoster. 58 42
181 children with
Hodgkin's disease
were analyzed with respect to the occurrence of
herpes zoster
and varicella (HZ-V) infections, possible contributing factors, and prognostic significance. The overall frequency of HZ-V was 34.8%. The occurrence in stage I was significantly lower than in other stages. Previous splenectomy was not found to increase significantly the risk of infection. High-risk patients were those receiving extensive radiotherapy plus combination chemotherapy; 56% developed HZ-V infections in this group. The frequency with extensive field radiotherapy alone was 23.8%. 80% of infections occurred during the first year after completion of treatment. Their occurrence was not a poor prognostic sign in terms of relapse or fatality, even when occurring late. The high frequency of disseminated infection (27%) with its subsequent morbidity should lead toward a better understanding of the immunologic deficiencies in these patients and the possible role of prophylactic measures, in patients undergoing extensive radiotherapy in combination with multiagent chemotherapy.
...
PMID:Herpes zoster and varicella infections in children with Hodgkin's disease: an analysis of contributing factors. 62 45
One hundred twenty-seven patients with
Hodgkin's disease
, Stages III-IV, received total nodal irradiation. Of these, 101 patients were managed primarily by radiation therapy employing the split course sequential segmental radiation technique called the "3 & 2". A dose of 3800-4000 rad is delivered in 2 phases in an overall period of 12 to 13 weeks (TDF 61-64; 1094-1148 rets). For various reasons, the remaining 26 patients received their mantle irradiation to full doses 3800-4000 rad in 4 weeks (TDF 63-66; 1112-1184 rets) without rest periods and a few were irradiated after failing chemotherapy. Of the 101 patients treated between 1969-1974 using the "3 & 2" technique, 2 developed pericarditis (2.0%), none manifested symptomatic pneumonitis (0%), and 3 hypothyroidism )3.0%). The low incidence of severe complications is primarily the result of the technique employed to give total nodal irradiation. The overall incidence of
Herpes Zoster
was 42% (53/127), and there was a slightly higher incidence when TNI was given following splenectomy.
...
PMID:Complications of total nodal irradiation of Hodgkin's disease stages III and IV. 67 47
Between 1967 and 1977, 48 patients with
Hodgkin's disease
under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available. Thirty-eight percent had early stage disease (stages I-IIIA). Prolonged first remissions were achieved in 74% of 42 complete responders. Of 11 patients who relapsed, 5 had prolonged second remissions induced by MOPP. Three patients were lost to follow-up and 15 of the remaining 45 died: 12 of these from progressive
Hodgkin's disease
, 2 from unrelated causes and 1 from Burkitt's lymphoma after 4 months remission from
Hodgkin's disease
. Acturial survival for all patients is 67% (75% for stages I-IIIA and 60% for stages IIIB-IV). Treatment complications included
Herpes zoster
and gynaecomastia. The latter is probably related to gonadal dysfunction. All stages of childhood Hodgkin's disease can be successfully managed with MOPP chemotherapy alone.
...
PMID:Childhood Hodgkin's disease in Uganda: a ten year experience. 68 86
Varicella and primary varicella pneumonia occurred in a patient with advanced
Hodgkin's disease
. The radiological characteristics are shown. Various relations between varicella,
herpes zoster
infections and
Hodgkin's disease
are discussed briefly.
...
PMID:[Varicella pneumonia in a patient with Hodgkin's disease (author's transl)]. 70 32
The rate of occurrence of
herpes zoster
(HZ) was analyzed by the life table method in 108
Hodgkin's disease
(HD) patients, diagnosed and treated during the years 1969 to 1976. Three groups, divided according to the degree of severity of the disease, were compared. The cumulative rate of occurrence of HZ at the end of the third year after diagnosis was higher in the group with intermediately extensive disease than in that with the most extensive disease (35 vs. 23%), but the difference was not significant. At the end of the fifth year, the rate was almost identical in both groups (35.3 and 35.6%, respectively). The group with the least severe form of HD had a very low HZ rate (2.2%), which was significantly different from the other two groups and close to the rate reported for normal populations. The five-year mortality rate was 0.0, 20.3 and 40.6%, respectively, in the three groups. These findings were interpreted to mean that in more advanced stages of HD, therapy and not the severity of the disease is the main factor determining the incidence of HZ. Extended field irradiation followed by a few courses of combined chemotherapy appear to have an effect similar to that of prolonged chemotherapy.
...
PMID:The relation between therapy and herpes zoster in Hodgkin's disease. 73 66
The records of 360 patients with malignant lymphoma treated with various forms of combination chemotherapy from 1966 to 1974 were reviewed. A total of 181 infections was found in 125 patients. The most frequent types of infection were pneumonia (31%), skin infections (17%), urinary tract infections (13%) and septicemia (11%). An etiologic organism was was identified in 133 infections (73%). The most common causative organisms were bacteria (77%), especially gram-negative bacilli. Viral infections accounted for 18% of the infections with 21 of the 24 being due to
herpes zoster
. These were more frequently found in patients with
Hodgkin's disease
(14/21) than in the other lymphomas. Among patients with
Hodgkin's disease
, 53% treated with COP developed infections compared to only 27% treated with MOPP (p = 0.039). Among patients with non-Hodgkin's lymphoma, infections were more frequent in patients treated with Adriamycin containing combinations than with COP. Neutropenia (i.e. less than 1,000 neutrophils/mm3) was associated with 35% of infections in this study and was seen more often in patients with non-Hodgkin's lymphoma (p = 0.048).
...
PMID:Infections in patients with malignant lymphoma treated with combination chemotherapy. 91 45
Sixty-two patients with
Hodgkin's disease
have been followed for one year from the start of treatment. Immunological assessments were repeated after intensive treatment, in patients relapsing and in those in remission at one year. In patients achieving remission, overall cellular immunity, after deteriorating with therapy, particularly cytotoxic chemotherapy, returned to pre-treatment levels in remission when there was little evidence of cellular immune disturbance. Serum IgG and IgM levels fell with intensive chemotherapy in splenectomized patients. IgA and IgM levels were lower (irrespective of splenectomy or therapy status) in remission than at presentation or after treatment. Relapse or non-response was usually associated with deteriorating cellular immunity.
Herpes zoster
/varicella and candida infections (seen in 6 patients) were preceded by, or associated with, deterioration of cellular immunity.
...
PMID:Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remission. 92 91
A patient with
Hodgkin's disease
with acute urinary retention caused by
herpes zoster
is presented. Two other similar cases previously reported in the literature are reviewed along with a review of English literature on
herpes zoster
causing urinary retention and on other genitourinary problems in
Hodgkin's disease
. Because of increased incidence of
herpes zoster
in
Hodgkin's disease
, recognition of this complication is stressed since other causes of actue urinary retention in
Hodgkin's disease
have serious implications.
...
PMID:Herpes zoster induced urinary retention in Hodgkin's disease. 115 96
Infections that occurrred in 92 previously untreated patients with
Hodgkin's disease
were reviewed from the time of laprotomy and splenectomy. Pneumonias occurred in nine patients with urinary tract infections in twelve during the immediate postoperative period. Severe bacterial infections did not occur in any patients during initial radiation therapy, adjuvant chemotherapy (stages I through IIIA), initial intensive chemotherapy (stages IIIB and IV) or during remission. Severe infections occurred in eight profoundly granulocytopenic patients with recurrent
Hodgkin's disease
. Streptococcus (Diplococcus) pneumoniae and Hemophilus spp infections were distinctly uncommon during the remission period.
Herpes zoster
, however, was very common developing in 22 of 92 (24 per cent) patients. Predisposing factors to
herpes zoster
included sex (female more than male), therapy (radiation plus chemotherapy more than chemotherapy alone), and age (less than 30 years of age more often than 30 to 50 years of age). Severe infection was uncommon in these patients except in ascociation with specific predisposing factors such as the immediate postoperative state of prolonged granulocytopenia associated with recurrent
Hodgkin's disease
or its therapy. Splenectomy per se did not affect either the incidence or the severity of infection during this period of 12+ months of observations per patient.
...
PMID:Infections in 92 splenectomized patients with Hodgkin's disease. A clinical review. 120 37
<< Previous
1
2
3
4
5
6
7
8
Next >>